File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/j.1600-0765.2011.01425.x
- Scopus: eid_2-s2.0-84857447017
- PMID: 22029638
- WOS: WOS:000300696300012
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Protease inhibitor levels in periodontal health and disease
Title | Protease inhibitor levels in periodontal health and disease |
---|---|
Authors | |
Keywords | Gingival crevicular fluid Periodontitis Protease inhibitor Porphyromonas gingivalis |
Issue Date | 2012 |
Citation | Journal of Periodontal Research, 2012, v. 47, n. 2, p. 228-235 How to Cite? |
Abstract | Background and Objective: Our previous study showed that protease inhibitors were attenuated by the periodontal pathogen Porphyromonas gingivalis in cultured gingival epithelial cells. We hypothesize that fewer protease inhibitors would be present in more advanced periodontal disease sites, where the level of P. gingivalis may be high. The goal of this study was to investigate the relationship between the protease inhibitor [secretory leukocyte protease inhibitor (SLPI), elastase-specific inhibitor (ELAFIN) and squamous cell carcinoma antigen (SCCA)] levels in gingival crevicular fluid and the number of P. gingivalis micro-organisms in subgingival plaque. Material and Methods: Plaque samples from subjects without (n=18) and with moderate to advanced periodontitis (n=41) were used to quantify P. gingivalis using real-time PCR. Protease inhibitor levels in the gingival crevicular fluid of all the subjects were determined by ELISA. Results: P. gingivalis was detected in 68.3% of patients with periodontitis, while 16.7% of subjects without periodontitis had a detectable level of P. gingivalis. Patients with periodontitis and P. gingivalis in their plaque exhibited lower SLPI and ELAFIN levels (p<0.001) compared with control subjects without periodontitis. Secretory leukocyte protease inhibitor was also reduced (p<0.05) in gingival crevicular fluid of periodontitis patients without a detectable level of P. gingivalis. Periodontitis patients with high vs. low levels of P. gingivalis exhibited reciprocal mean levels of SLPI and ELAFIN concentrations. Conclusion: The reduced concentrations of SLPI and ELAFIN may contribute to the loss of host protective capacity and increase susceptibility to breakdown from chronic infection. The work of this investigation may aid in finding diagnostic and prognostic markers in periodontal health and disease and may also help in finding pharmacological targets directed against periodontal inflammation. © 2011 John Wiley & Sons A/S. |
Persistent Identifier | http://hdl.handle.net/10722/200093 |
ISSN | 2023 Impact Factor: 3.4 2023 SCImago Journal Rankings: 0.895 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kretschmar, S. | - |
dc.contributor.author | Yin, Lei | - |
dc.contributor.author | Roberts, Frank A. | - |
dc.contributor.author | London, Robert M. | - |
dc.contributor.author | Flemmig, Thomas Frank | - |
dc.contributor.author | Arushanov, Daniyel | - |
dc.contributor.author | Kaiyala, Karl J. | - |
dc.contributor.author | Chung, Whasunoh | - |
dc.date.accessioned | 2014-07-26T23:11:07Z | - |
dc.date.available | 2014-07-26T23:11:07Z | - |
dc.date.issued | 2012 | - |
dc.identifier.citation | Journal of Periodontal Research, 2012, v. 47, n. 2, p. 228-235 | - |
dc.identifier.issn | 0022-3484 | - |
dc.identifier.uri | http://hdl.handle.net/10722/200093 | - |
dc.description.abstract | Background and Objective: Our previous study showed that protease inhibitors were attenuated by the periodontal pathogen Porphyromonas gingivalis in cultured gingival epithelial cells. We hypothesize that fewer protease inhibitors would be present in more advanced periodontal disease sites, where the level of P. gingivalis may be high. The goal of this study was to investigate the relationship between the protease inhibitor [secretory leukocyte protease inhibitor (SLPI), elastase-specific inhibitor (ELAFIN) and squamous cell carcinoma antigen (SCCA)] levels in gingival crevicular fluid and the number of P. gingivalis micro-organisms in subgingival plaque. Material and Methods: Plaque samples from subjects without (n=18) and with moderate to advanced periodontitis (n=41) were used to quantify P. gingivalis using real-time PCR. Protease inhibitor levels in the gingival crevicular fluid of all the subjects were determined by ELISA. Results: P. gingivalis was detected in 68.3% of patients with periodontitis, while 16.7% of subjects without periodontitis had a detectable level of P. gingivalis. Patients with periodontitis and P. gingivalis in their plaque exhibited lower SLPI and ELAFIN levels (p<0.001) compared with control subjects without periodontitis. Secretory leukocyte protease inhibitor was also reduced (p<0.05) in gingival crevicular fluid of periodontitis patients without a detectable level of P. gingivalis. Periodontitis patients with high vs. low levels of P. gingivalis exhibited reciprocal mean levels of SLPI and ELAFIN concentrations. Conclusion: The reduced concentrations of SLPI and ELAFIN may contribute to the loss of host protective capacity and increase susceptibility to breakdown from chronic infection. The work of this investigation may aid in finding diagnostic and prognostic markers in periodontal health and disease and may also help in finding pharmacological targets directed against periodontal inflammation. © 2011 John Wiley & Sons A/S. | - |
dc.language | eng | - |
dc.relation.ispartof | Journal of Periodontal Research | - |
dc.subject | Gingival crevicular fluid | - |
dc.subject | Periodontitis | - |
dc.subject | Protease inhibitor | - |
dc.subject | Porphyromonas gingivalis | - |
dc.title | Protease inhibitor levels in periodontal health and disease | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1111/j.1600-0765.2011.01425.x | - |
dc.identifier.pmid | 22029638 | - |
dc.identifier.scopus | eid_2-s2.0-84857447017 | - |
dc.identifier.volume | 47 | - |
dc.identifier.issue | 2 | - |
dc.identifier.spage | 228 | - |
dc.identifier.epage | 235 | - |
dc.identifier.eissn | 1600-0765 | - |
dc.identifier.isi | WOS:000300696300012 | - |
dc.identifier.issnl | 0022-3484 | - |